Psoriasis: response to high-dose intravenous immunoglobulin in three patients
β Scribed by V. Gurmin; R. Mediwake; M. Fernando; S. Whittaker; M.H.A. Rustin; H.L.C. Beynon
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 59 KB
- Volume
- 147
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
β¦ Synopsis
Treatment of recalcitrant psoriasis and psoriatic arthritis can be challenging, with treatment options limited by drug intolerance or poor efficacy. High-dose intravenous immunoglobulin (hdIVIg) has been used successfully in Kawasaki's disease and idiopathic thrombocytopenic purpura, where it has become the standard treatment. The literature also suggests its positive effect in the treatment of dermatological conditions, such as autoimmune chronic urticaria, atopic dermatitis, scleromyxoedema, dermatomyositis and autoimmune bullous disorders. We report three patients with treatment-resistant psoriasis and psoriatic arthritis who improved with hdIVIg.
π SIMILAR VOLUMES
Cytopenias following bone marrow transplantation may be severe and life-threatening. These have been described post-allogeneic Klumpp, 1991 : Bone Marrow Transplant 8:159-171. or post-autologous bone marrow transplants
## Abstract A 42βyearβold male with stage IV mantle cell lymphoma received chemotherapy and autologous peripheral blood stem cell transplantation. He developed pancytopaenia, and bone marrow examination indicated a parvovirus B19 (PVB 19)βinduced red cell aplasia, confirmed by virological tests. Mu